Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of $65M in penalties 0 07.10.2024 18:52 New York Post The judge cited Shkreli's "particularly heartless and coercive" tactics in monopolizing Daraprim and keeping generic rivals off the market. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
